UK markets closed

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.50-0.11 (-1.66%)
As of 12:04PM EDT. Market open.

TherapeuticsMD, Inc.

951 Yamato Road
Suite 220
Boca Raton, FL 33431
United States
561 961 1900

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees416

Key executives

NameTitlePayExercisedYear born
Governor Thomas G. ThompsonExec. Chairman100kN/A1942
Mr. Hugh O'Dowd M.B.A.Pres & Director1.19MN/A1965
Mr. Robert G. FinizioCo-Founder2.53MN/A1971
Mr. Marlan D. Walker J.D.Gen. Counsel & Secretay506.21kN/A1975
Dr. Brian A. Bernick F.A.C.O.G., M.D.Co-Founder,Co-CEO & Chief Medical OfficerN/AN/A1968
Mr. Mark A. GlickmanCo-CEO & Chief Bus. OfficerN/AN/A1966
Mr. Michael C. DoneganInterim CFO, Chief Accounting Officer and Principal Financial & Accounting OfficerN/AN/A1968
Ms. Daniella SilvaChief Compliance OfficerN/AN/A1986
Mr. Benjamin FoulkVP of HRN/AN/A1970
Mr. Mitchell L. KrassanExec. VP and Chief Strategy & Performance OfficerN/AN/A1966
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Corporate governance

TherapeuticsMD, Inc.’s ISS governance QualityScore as of 1 October 2022 is 5. The pillar scores are Audit: 4; Board: 8; Shareholder rights: 2; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.